Piramal Pharma Limited announced levying the following penalties: INR 9,335,983 under the Cenvat Credit Rules, 2004 and Central Excise Act, 1944 by way of an order dated June 27, 2024 passed by the Joint Commissioner, C.G.S.T & Central Excise Headquarters, Ujjain, disallowing cenvat credit on certain category of services; and INR 58,661,571 under Central Goods and Services Tax, 2017 by way of an order dated May 31, 2024 passed by the Joint Commissioner, C.G.S.T & Central Excise, Commissionerate Indore, alleging mixed supply of goods and that this is subject to higher rate of GST; (collectively `Orders').